Comparing eye disease prevalence in diabetic and healthy children
Official title: Shanghai Children and Adolescent Diabetes Eye Study
Run by Shanghai Eye Disease Prevention and Treatment Center · NCT03587948 · Data updated 2026-11-12
This study looks at how common eye diseases are in children with diabetes compared to healthy kids to help improve eye care for those with diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 18 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Shanghai Eye Disease Prevention and Treatment Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | January 1, 2018 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2028 |
| Registry record updated | July 16, 2018 |
| Trial ID | NCT03587948 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 5 to 18 years who have been diagnosed with type 1 or type 2 diabetes.
✕Probably not a fit
Patients with specific ocular conditions or systemic diseases that could affect eye health may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to compare the prevalence of eye diseases between children and adolescents diagnosed with diabetes mellitus and a control group of healthy children. Conducted at the Children's Hospital of Fudan University in Shanghai from 2018 to 2028, the study will enroll 300 diabetic children and 300 healthy children. The research will analyze factors related to eye diseases in diabetic patients to improve screening and management of diabetic eye health. The ultimate goal is to reduce the rates of diabetic eye disease and enhance awareness of eye health among diabetic youth.
Why it matters
Potential benefit: If successful, this study could lead to improved screening and management of eye health in children with diabetes, potentially reducing the incidence of blindness and visual impairment.
How similar studies have gone: Other studies have shown success in understanding the relationship between diabetes and eye diseases, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) provision of a written informed consent by a guardian; * (2) age over 5 years and less than 18 years; * (3) diagnosis of type 1 or type 2 diabetes based on the WHO diagnostic criteria for cases. Exclusion Criteria: * (1) eyelid diseases - eyelid entropion, eyelid ectropion, eyelid, ptosis, and palpebral dyskinesia; * (2) conjunctival diseases - pterygium and conjunctivitis; * (3) history of ocular surface chemical injury or use of eye drops with moisturizing artificial tears; * (4) history of eye surgery within 6 months or history of retinal laser photocoagulation; * (5) systemic diseases - Sjogren syndrome, Parkinson's disease, rheumatoid arthritis, Grave 's disease, systemic lupus erythematosus, and others.
Where it's running
-
Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Haidong Zou, post-doctor
- Email: zouhaidong@263.net
- Phone: 13311986528
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ETHY-001 safety and activity in Thyroid Eye Disease (TED)
This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.